ウイルス不活化キットのグローバル市場予測2023-2029

◆英語タイトル:Global Viral Inactivation Kits Market Growth 2023-2029

LP Informationが発行した調査報告書(LP23MY3884)◆商品コード:LP23MY3884
◆発行会社(リサーチ会社):LP Information
◆発行日:2023年5月
◆ページ数:103
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後2-3営業日)
◆調査対象地域:グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
◆産業分野:医療機器&消耗品
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,660 ⇒換算¥556,320見積依頼/購入/質問フォーム
Multi User(20名様閲覧用)USD5,490 ⇒換算¥834,480見積依頼/購入/質問フォーム
Corporate User(閲覧人数制限なし)USD7,320 ⇒換算¥1,112,640見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

LP Informationの最新刊調査レポート「ウイルス不活化キットのグローバル市場」は、過去の販売実績から2022年の世界のウイルス不活化キットの総販売量を検討し、2023年から2029年の予測されるウイルス不活化キットの販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別のウイルス不活化キットの市場規模を掲載し、XXX百万米ドル規模の世界のウイルス不活化キット市場の詳細な分析を提供します。本インサイトレポートは、世界のウイルス不活化キット業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界のウイルス不活化キット市場における各社の独自のポジションをより深く理解するために、ウイルス不活化キット製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界のウイルス不活化キット市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。ウイルス不活化キットの米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000%と予測されています。ウイルス不活化キットの中国市場は、2023年から2029年までの年平均000%成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。ウイルス不活化キットのヨーロッパ市場は、2023年から2029年にかけて年平均000%成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

ウイルス不活化キットの世界主要メーカーとしては、Merck KGAA、 Danaher Corporation、 Texcell Inc、 Sartorius AG、 Wuxi Pharmatech (Cayman) Inc、 Viral Inactivated Plasma Systems SA、 Clean Cells Inc、 Parker Hannifin Corporation、 SGS SA、 Charles River Laboratories International Inc、 Rad Source Technologies Inc、 HiMedia Laboratories Pvt Ltdなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000%のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別のウイルス不活化キット市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場セグメンテーション】

この調査ではウイルス不活化キット市場をセグメンテーションし、種類別 (使い捨て使用、再使用可能)、用途別 (病院、科学研究、診断センター)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分:使い捨て使用、再使用可能

・用途別区分:病院、科学研究、診断センター

・地域別区分
南北アメリカ(米国、カナダ、メキシコ、ブラジル)
アジア太平洋(中国、日本、韓国、東南アジア、インド、オーストラリア)
ヨーロッパ(ドイツ、フランス、イギリス、イタリア、ロシア)
中東・アフリカ(エジプト、南アフリカ、イスラエル、トルコ、GCC諸国)

【本レポートで扱う主な質問】

・世界のウイルス不活化キット市場の10年間の市場状況・展望は?
・世界および地域別に見たウイルス不活化キット市場成長の要因は何か?
・ウイルス不活化キットの市場機会はエンドマーケットの規模によってどのように変化するのか?
・ウイルス不活化キットのタイプ別、用途別の内訳は?
・新型コロナウイルスとロシア・ウクライナ戦争の影響は?

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要:ウイルス不活化キットの年間販売量2018-2029、地域別現状・将来分析
・ウイルス不活化キットの種類別セグメント:使い捨て使用、再使用可能
・ウイルス不活化キットの種類別販売量:2018-2023年の販売量、売上、市場シェア、販売価格
・ウイルス不活化キットの用途別セグメント:病院、科学研究、診断センター
・ウイルス不活化キットの用途別販売量:2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界のウイルス不活化キット市場
・企業別のグローバルウイルス不活化キット市場データ:2018-2023年の年間販売量、市場シェア
・企業別のウイルス不活化キットの年間売上:2018-2023年の売上、市場シェア
・企業別のウイルス不活化キット販売価格
・主要企業のウイルス不活化キット生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

ウイルス不活化キットの地域別レビュー
・地域別のウイルス不活化キット市場規模2018-2023:年間販売量、売上
・主要国別のウイルス不活化キット市場規模2018-2023:年間販売量、売上
・南北アメリカのウイルス不活化キット販売の成長
・アジア太平洋のウイルス不活化キット販売の成長
・ヨーロッパのウイルス不活化キット販売の成長
・中東・アフリカのウイルス不活化キット販売の成長

南北アメリカ市場
・南北アメリカの国別のウイルス不活化キット販売量、売上(2018-2023)
・南北アメリカのウイルス不活化キットの種類別販売量
・南北アメリカのウイルス不活化キットの用途別販売量
・米国市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別のウイルス不活化キット販売量、売上(2018-2023)
・アジア太平洋のウイルス不活化キットの種類別販売量
・アジア太平洋のウイルス不活化キットの用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別のウイルス不活化キット販売量、売上(2018-2023)
・ヨーロッパのウイルス不活化キットの種類別販売量
・ヨーロッパのウイルス不活化キットの用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別のウイルス不活化キット販売量、売上(2018-2023)
・中東・アフリカのウイルス不活化キットの種類別販売量
・中東・アフリカのウイルス不活化キットの用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・ウイルス不活化キットの製造コスト構造分析
・ウイルス不活化キットの製造プロセス分析
・ウイルス不活化キットの産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル:直接販売チャンネル、間接販売チャンネル
・ウイルス不活化キットの主要なグローバル販売業者
・ウイルス不活化キットの主要なグローバル顧客

地域別のウイルス不活化キット市場予測レビュー
・地域別のウイルス不活化キット市場規模予測(2024-2029)
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・ウイルス不活化キットの種類別市場規模予測
・ウイルス不活化キットの用途別市場規模予測

主要企業分析
Merck KGAA、 Danaher Corporation、 Texcell Inc、 Sartorius AG、 Wuxi Pharmatech (Cayman) Inc、 Viral Inactivated Plasma Systems SA、 Clean Cells Inc、 Parker Hannifin Corporation、 SGS SA、 Charles River Laboratories International Inc、 Rad Source Technologies Inc、 HiMedia Laboratories Pvt Ltd
・企業情報
・ウイルス不活化キット製品
・ウイルス不活化キット販売量、売上、価格、粗利益(2018-2023)
・主要ビジネス概要
・最新動向

調査結果および結論

LPI (LP Information)’ newest research report, the “Viral Inactivation Kits Industry Forecast” looks at past sales and reviews total world Viral Inactivation Kits sales in 2022, providing a comprehensive analysis by region and market sector of projected Viral Inactivation Kits sales for 2023 through 2029. With Viral Inactivation Kits sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Viral Inactivation Kits industry.
This Insight Report provides a comprehensive analysis of the global Viral Inactivation Kits landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Viral Inactivation Kits portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Viral Inactivation Kits market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Viral Inactivation Kits and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Viral Inactivation Kits.
The global Viral Inactivation Kits market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Viral Inactivation Kits is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Viral Inactivation Kits is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Viral Inactivation Kits is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Viral Inactivation Kits players cover Merck KGAA, Danaher Corporation, Texcell Inc, Sartorius AG, Wuxi Pharmatech (Cayman) Inc, Viral Inactivated Plasma Systems SA, Clean Cells Inc, Parker Hannifin Corporation and SGS SA, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Viral Inactivation Kits market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Disposable Use
Reusable Use
Segmentation by application
Hospital
Scientific Research
Diagnostic Center
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
Merck KGAA
Danaher Corporation
Texcell Inc
Sartorius AG
Wuxi Pharmatech (Cayman) Inc
Viral Inactivated Plasma Systems SA
Clean Cells Inc
Parker Hannifin Corporation
SGS SA
Charles River Laboratories International Inc
Rad Source Technologies Inc
HiMedia Laboratories Pvt Ltd
Key Questions Addressed in this Report
What is the 10-year outlook for the global Viral Inactivation Kits market?
What factors are driving Viral Inactivation Kits market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Viral Inactivation Kits market opportunities vary by end market size?
How does Viral Inactivation Kits break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Viral Inactivation Kits Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Viral Inactivation Kits by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Viral Inactivation Kits by Country/Region, 2018, 2022 & 2029
2.2 Viral Inactivation Kits Segment by Type
2.2.1 Disposable Use
2.2.2 Reusable Use
2.3 Viral Inactivation Kits Sales by Type
2.3.1 Global Viral Inactivation Kits Sales Market Share by Type (2018-2023)
2.3.2 Global Viral Inactivation Kits Revenue and Market Share by Type (2018-2023)
2.3.3 Global Viral Inactivation Kits Sale Price by Type (2018-2023)
2.4 Viral Inactivation Kits Segment by Application
2.4.1 Hospital
2.4.2 Scientific Research
2.4.3 Diagnostic Center
2.5 Viral Inactivation Kits Sales by Application
2.5.1 Global Viral Inactivation Kits Sale Market Share by Application (2018-2023)
2.5.2 Global Viral Inactivation Kits Revenue and Market Share by Application (2018-2023)
2.5.3 Global Viral Inactivation Kits Sale Price by Application (2018-2023)
3 Global Viral Inactivation Kits by Company
3.1 Global Viral Inactivation Kits Breakdown Data by Company
3.1.1 Global Viral Inactivation Kits Annual Sales by Company (2018-2023)
3.1.2 Global Viral Inactivation Kits Sales Market Share by Company (2018-2023)
3.2 Global Viral Inactivation Kits Annual Revenue by Company (2018-2023)
3.2.1 Global Viral Inactivation Kits Revenue by Company (2018-2023)
3.2.2 Global Viral Inactivation Kits Revenue Market Share by Company (2018-2023)
3.3 Global Viral Inactivation Kits Sale Price by Company
3.4 Key Manufacturers Viral Inactivation Kits Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Viral Inactivation Kits Product Location Distribution
3.4.2 Players Viral Inactivation Kits Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Viral Inactivation Kits by Geographic Region
4.1 World Historic Viral Inactivation Kits Market Size by Geographic Region (2018-2023)
4.1.1 Global Viral Inactivation Kits Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Viral Inactivation Kits Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Viral Inactivation Kits Market Size by Country/Region (2018-2023)
4.2.1 Global Viral Inactivation Kits Annual Sales by Country/Region (2018-2023)
4.2.2 Global Viral Inactivation Kits Annual Revenue by Country/Region (2018-2023)
4.3 Americas Viral Inactivation Kits Sales Growth
4.4 APAC Viral Inactivation Kits Sales Growth
4.5 Europe Viral Inactivation Kits Sales Growth
4.6 Middle East & Africa Viral Inactivation Kits Sales Growth
5 Americas
5.1 Americas Viral Inactivation Kits Sales by Country
5.1.1 Americas Viral Inactivation Kits Sales by Country (2018-2023)
5.1.2 Americas Viral Inactivation Kits Revenue by Country (2018-2023)
5.2 Americas Viral Inactivation Kits Sales by Type
5.3 Americas Viral Inactivation Kits Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Viral Inactivation Kits Sales by Region
6.1.1 APAC Viral Inactivation Kits Sales by Region (2018-2023)
6.1.2 APAC Viral Inactivation Kits Revenue by Region (2018-2023)
6.2 APAC Viral Inactivation Kits Sales by Type
6.3 APAC Viral Inactivation Kits Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Viral Inactivation Kits by Country
7.1.1 Europe Viral Inactivation Kits Sales by Country (2018-2023)
7.1.2 Europe Viral Inactivation Kits Revenue by Country (2018-2023)
7.2 Europe Viral Inactivation Kits Sales by Type
7.3 Europe Viral Inactivation Kits Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Viral Inactivation Kits by Country
8.1.1 Middle East & Africa Viral Inactivation Kits Sales by Country (2018-2023)
8.1.2 Middle East & Africa Viral Inactivation Kits Revenue by Country (2018-2023)
8.2 Middle East & Africa Viral Inactivation Kits Sales by Type
8.3 Middle East & Africa Viral Inactivation Kits Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Viral Inactivation Kits
10.3 Manufacturing Process Analysis of Viral Inactivation Kits
10.4 Industry Chain Structure of Viral Inactivation Kits
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Viral Inactivation Kits Distributors
11.3 Viral Inactivation Kits Customer
12 World Forecast Review for Viral Inactivation Kits by Geographic Region
12.1 Global Viral Inactivation Kits Market Size Forecast by Region
12.1.1 Global Viral Inactivation Kits Forecast by Region (2024-2029)
12.1.2 Global Viral Inactivation Kits Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Viral Inactivation Kits Forecast by Type
12.7 Global Viral Inactivation Kits Forecast by Application
13 Key Players Analysis
13.1 Merck KGAA
13.1.1 Merck KGAA Company Information
13.1.2 Merck KGAA Viral Inactivation Kits Product Portfolios and Specifications
13.1.3 Merck KGAA Viral Inactivation Kits Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Merck KGAA Main Business Overview
13.1.5 Merck KGAA Latest Developments
13.2 Danaher Corporation
13.2.1 Danaher Corporation Company Information
13.2.2 Danaher Corporation Viral Inactivation Kits Product Portfolios and Specifications
13.2.3 Danaher Corporation Viral Inactivation Kits Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Danaher Corporation Main Business Overview
13.2.5 Danaher Corporation Latest Developments
13.3 Texcell Inc
13.3.1 Texcell Inc Company Information
13.3.2 Texcell Inc Viral Inactivation Kits Product Portfolios and Specifications
13.3.3 Texcell Inc Viral Inactivation Kits Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Texcell Inc Main Business Overview
13.3.5 Texcell Inc Latest Developments
13.4 Sartorius AG
13.4.1 Sartorius AG Company Information
13.4.2 Sartorius AG Viral Inactivation Kits Product Portfolios and Specifications
13.4.3 Sartorius AG Viral Inactivation Kits Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Sartorius AG Main Business Overview
13.4.5 Sartorius AG Latest Developments
13.5 Wuxi Pharmatech (Cayman) Inc
13.5.1 Wuxi Pharmatech (Cayman) Inc Company Information
13.5.2 Wuxi Pharmatech (Cayman) Inc Viral Inactivation Kits Product Portfolios and Specifications
13.5.3 Wuxi Pharmatech (Cayman) Inc Viral Inactivation Kits Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Wuxi Pharmatech (Cayman) Inc Main Business Overview
13.5.5 Wuxi Pharmatech (Cayman) Inc Latest Developments
13.6 Viral Inactivated Plasma Systems SA
13.6.1 Viral Inactivated Plasma Systems SA Company Information
13.6.2 Viral Inactivated Plasma Systems SA Viral Inactivation Kits Product Portfolios and Specifications
13.6.3 Viral Inactivated Plasma Systems SA Viral Inactivation Kits Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Viral Inactivated Plasma Systems SA Main Business Overview
13.6.5 Viral Inactivated Plasma Systems SA Latest Developments
13.7 Clean Cells Inc
13.7.1 Clean Cells Inc Company Information
13.7.2 Clean Cells Inc Viral Inactivation Kits Product Portfolios and Specifications
13.7.3 Clean Cells Inc Viral Inactivation Kits Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Clean Cells Inc Main Business Overview
13.7.5 Clean Cells Inc Latest Developments
13.8 Parker Hannifin Corporation
13.8.1 Parker Hannifin Corporation Company Information
13.8.2 Parker Hannifin Corporation Viral Inactivation Kits Product Portfolios and Specifications
13.8.3 Parker Hannifin Corporation Viral Inactivation Kits Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Parker Hannifin Corporation Main Business Overview
13.8.5 Parker Hannifin Corporation Latest Developments
13.9 SGS SA
13.9.1 SGS SA Company Information
13.9.2 SGS SA Viral Inactivation Kits Product Portfolios and Specifications
13.9.3 SGS SA Viral Inactivation Kits Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 SGS SA Main Business Overview
13.9.5 SGS SA Latest Developments
13.10 Charles River Laboratories International Inc
13.10.1 Charles River Laboratories International Inc Company Information
13.10.2 Charles River Laboratories International Inc Viral Inactivation Kits Product Portfolios and Specifications
13.10.3 Charles River Laboratories International Inc Viral Inactivation Kits Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Charles River Laboratories International Inc Main Business Overview
13.10.5 Charles River Laboratories International Inc Latest Developments
13.11 Rad Source Technologies Inc
13.11.1 Rad Source Technologies Inc Company Information
13.11.2 Rad Source Technologies Inc Viral Inactivation Kits Product Portfolios and Specifications
13.11.3 Rad Source Technologies Inc Viral Inactivation Kits Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Rad Source Technologies Inc Main Business Overview
13.11.5 Rad Source Technologies Inc Latest Developments
13.12 HiMedia Laboratories Pvt Ltd
13.12.1 HiMedia Laboratories Pvt Ltd Company Information
13.12.2 HiMedia Laboratories Pvt Ltd Viral Inactivation Kits Product Portfolios and Specifications
13.12.3 HiMedia Laboratories Pvt Ltd Viral Inactivation Kits Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 HiMedia Laboratories Pvt Ltd Main Business Overview
13.12.5 HiMedia Laboratories Pvt Ltd Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Viral Inactivation Kits Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Viral Inactivation Kits Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Disposable Use
Table 4. Major Players of Reusable Use
Table 5. Global Viral Inactivation Kits Sales by Type (2018-2023) & (K Units)
Table 6. Global Viral Inactivation Kits Sales Market Share by Type (2018-2023)
Table 7. Global Viral Inactivation Kits Revenue by Type (2018-2023) & ($ million)
Table 8. Global Viral Inactivation Kits Revenue Market Share by Type (2018-2023)
Table 9. Global Viral Inactivation Kits Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Viral Inactivation Kits Sales by Application (2018-2023) & (K Units)
Table 11. Global Viral Inactivation Kits Sales Market Share by Application (2018-2023)
Table 12. Global Viral Inactivation Kits Revenue by Application (2018-2023)
Table 13. Global Viral Inactivation Kits Revenue Market Share by Application (2018-2023)
Table 14. Global Viral Inactivation Kits Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Viral Inactivation Kits Sales by Company (2018-2023) & (K Units)
Table 16. Global Viral Inactivation Kits Sales Market Share by Company (2018-2023)
Table 17. Global Viral Inactivation Kits Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Viral Inactivation Kits Revenue Market Share by Company (2018-2023)
Table 19. Global Viral Inactivation Kits Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Viral Inactivation Kits Producing Area Distribution and Sales Area
Table 21. Players Viral Inactivation Kits Products Offered
Table 22. Viral Inactivation Kits Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Viral Inactivation Kits Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Viral Inactivation Kits Sales Market Share Geographic Region (2018-2023)
Table 27. Global Viral Inactivation Kits Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Viral Inactivation Kits Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Viral Inactivation Kits Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Viral Inactivation Kits Sales Market Share by Country/Region (2018-2023)
Table 31. Global Viral Inactivation Kits Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Viral Inactivation Kits Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Viral Inactivation Kits Sales by Country (2018-2023) & (K Units)
Table 34. Americas Viral Inactivation Kits Sales Market Share by Country (2018-2023)
Table 35. Americas Viral Inactivation Kits Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Viral Inactivation Kits Revenue Market Share by Country (2018-2023)
Table 37. Americas Viral Inactivation Kits Sales by Type (2018-2023) & (K Units)
Table 38. Americas Viral Inactivation Kits Sales by Application (2018-2023) & (K Units)
Table 39. APAC Viral Inactivation Kits Sales by Region (2018-2023) & (K Units)
Table 40. APAC Viral Inactivation Kits Sales Market Share by Region (2018-2023)
Table 41. APAC Viral Inactivation Kits Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Viral Inactivation Kits Revenue Market Share by Region (2018-2023)
Table 43. APAC Viral Inactivation Kits Sales by Type (2018-2023) & (K Units)
Table 44. APAC Viral Inactivation Kits Sales by Application (2018-2023) & (K Units)
Table 45. Europe Viral Inactivation Kits Sales by Country (2018-2023) & (K Units)
Table 46. Europe Viral Inactivation Kits Sales Market Share by Country (2018-2023)
Table 47. Europe Viral Inactivation Kits Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Viral Inactivation Kits Revenue Market Share by Country (2018-2023)
Table 49. Europe Viral Inactivation Kits Sales by Type (2018-2023) & (K Units)
Table 50. Europe Viral Inactivation Kits Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Viral Inactivation Kits Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Viral Inactivation Kits Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Viral Inactivation Kits Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Viral Inactivation Kits Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Viral Inactivation Kits Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Viral Inactivation Kits Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Viral Inactivation Kits
Table 58. Key Market Challenges & Risks of Viral Inactivation Kits
Table 59. Key Industry Trends of Viral Inactivation Kits
Table 60. Viral Inactivation Kits Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Viral Inactivation Kits Distributors List
Table 63. Viral Inactivation Kits Customer List
Table 64. Global Viral Inactivation Kits Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Viral Inactivation Kits Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Viral Inactivation Kits Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Viral Inactivation Kits Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Viral Inactivation Kits Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Viral Inactivation Kits Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Viral Inactivation Kits Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Viral Inactivation Kits Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Viral Inactivation Kits Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Viral Inactivation Kits Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Viral Inactivation Kits Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Viral Inactivation Kits Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Viral Inactivation Kits Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Viral Inactivation Kits Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Merck KGAA Basic Information, Viral Inactivation Kits Manufacturing Base, Sales Area and Its Competitors
Table 79. Merck KGAA Viral Inactivation Kits Product Portfolios and Specifications
Table 80. Merck KGAA Viral Inactivation Kits Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. Merck KGAA Main Business
Table 82. Merck KGAA Latest Developments
Table 83. Danaher Corporation Basic Information, Viral Inactivation Kits Manufacturing Base, Sales Area and Its Competitors
Table 84. Danaher Corporation Viral Inactivation Kits Product Portfolios and Specifications
Table 85. Danaher Corporation Viral Inactivation Kits Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. Danaher Corporation Main Business
Table 87. Danaher Corporation Latest Developments
Table 88. Texcell Inc Basic Information, Viral Inactivation Kits Manufacturing Base, Sales Area and Its Competitors
Table 89. Texcell Inc Viral Inactivation Kits Product Portfolios and Specifications
Table 90. Texcell Inc Viral Inactivation Kits Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. Texcell Inc Main Business
Table 92. Texcell Inc Latest Developments
Table 93. Sartorius AG Basic Information, Viral Inactivation Kits Manufacturing Base, Sales Area and Its Competitors
Table 94. Sartorius AG Viral Inactivation Kits Product Portfolios and Specifications
Table 95. Sartorius AG Viral Inactivation Kits Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. Sartorius AG Main Business
Table 97. Sartorius AG Latest Developments
Table 98. Wuxi Pharmatech (Cayman) Inc Basic Information, Viral Inactivation Kits Manufacturing Base, Sales Area and Its Competitors
Table 99. Wuxi Pharmatech (Cayman) Inc Viral Inactivation Kits Product Portfolios and Specifications
Table 100. Wuxi Pharmatech (Cayman) Inc Viral Inactivation Kits Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. Wuxi Pharmatech (Cayman) Inc Main Business
Table 102. Wuxi Pharmatech (Cayman) Inc Latest Developments
Table 103. Viral Inactivated Plasma Systems SA Basic Information, Viral Inactivation Kits Manufacturing Base, Sales Area and Its Competitors
Table 104. Viral Inactivated Plasma Systems SA Viral Inactivation Kits Product Portfolios and Specifications
Table 105. Viral Inactivated Plasma Systems SA Viral Inactivation Kits Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. Viral Inactivated Plasma Systems SA Main Business
Table 107. Viral Inactivated Plasma Systems SA Latest Developments
Table 108. Clean Cells Inc Basic Information, Viral Inactivation Kits Manufacturing Base, Sales Area and Its Competitors
Table 109. Clean Cells Inc Viral Inactivation Kits Product Portfolios and Specifications
Table 110. Clean Cells Inc Viral Inactivation Kits Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. Clean Cells Inc Main Business
Table 112. Clean Cells Inc Latest Developments
Table 113. Parker Hannifin Corporation Basic Information, Viral Inactivation Kits Manufacturing Base, Sales Area and Its Competitors
Table 114. Parker Hannifin Corporation Viral Inactivation Kits Product Portfolios and Specifications
Table 115. Parker Hannifin Corporation Viral Inactivation Kits Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 116. Parker Hannifin Corporation Main Business
Table 117. Parker Hannifin Corporation Latest Developments
Table 118. SGS SA Basic Information, Viral Inactivation Kits Manufacturing Base, Sales Area and Its Competitors
Table 119. SGS SA Viral Inactivation Kits Product Portfolios and Specifications
Table 120. SGS SA Viral Inactivation Kits Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 121. SGS SA Main Business
Table 122. SGS SA Latest Developments
Table 123. Charles River Laboratories International Inc Basic Information, Viral Inactivation Kits Manufacturing Base, Sales Area and Its Competitors
Table 124. Charles River Laboratories International Inc Viral Inactivation Kits Product Portfolios and Specifications
Table 125. Charles River Laboratories International Inc Viral Inactivation Kits Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 126. Charles River Laboratories International Inc Main Business
Table 127. Charles River Laboratories International Inc Latest Developments
Table 128. Rad Source Technologies Inc Basic Information, Viral Inactivation Kits Manufacturing Base, Sales Area and Its Competitors
Table 129. Rad Source Technologies Inc Viral Inactivation Kits Product Portfolios and Specifications
Table 130. Rad Source Technologies Inc Viral Inactivation Kits Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 131. Rad Source Technologies Inc Main Business
Table 132. Rad Source Technologies Inc Latest Developments
Table 133. HiMedia Laboratories Pvt Ltd Basic Information, Viral Inactivation Kits Manufacturing Base, Sales Area and Its Competitors
Table 134. HiMedia Laboratories Pvt Ltd Viral Inactivation Kits Product Portfolios and Specifications
Table 135. HiMedia Laboratories Pvt Ltd Viral Inactivation Kits Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 136. HiMedia Laboratories Pvt Ltd Main Business
Table 137. HiMedia Laboratories Pvt Ltd Latest Developments
List of Figures
Figure 1. Picture of Viral Inactivation Kits
Figure 2. Viral Inactivation Kits Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Viral Inactivation Kits Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Viral Inactivation Kits Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Viral Inactivation Kits Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Disposable Use
Figure 10. Product Picture of Reusable Use
Figure 11. Global Viral Inactivation Kits Sales Market Share by Type in 2022
Figure 12. Global Viral Inactivation Kits Revenue Market Share by Type (2018-2023)
Figure 13. Viral Inactivation Kits Consumed in Hospital
Figure 14. Global Viral Inactivation Kits Market: Hospital (2018-2023) & (K Units)
Figure 15. Viral Inactivation Kits Consumed in Scientific Research
Figure 16. Global Viral Inactivation Kits Market: Scientific Research (2018-2023) & (K Units)
Figure 17. Viral Inactivation Kits Consumed in Diagnostic Center
Figure 18. Global Viral Inactivation Kits Market: Diagnostic Center (2018-2023) & (K Units)
Figure 19. Global Viral Inactivation Kits Sales Market Share by Application (2022)
Figure 20. Global Viral Inactivation Kits Revenue Market Share by Application in 2022
Figure 21. Viral Inactivation Kits Sales Market by Company in 2022 (K Units)
Figure 22. Global Viral Inactivation Kits Sales Market Share by Company in 2022
Figure 23. Viral Inactivation Kits Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Viral Inactivation Kits Revenue Market Share by Company in 2022
Figure 25. Global Viral Inactivation Kits Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Viral Inactivation Kits Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Viral Inactivation Kits Sales 2018-2023 (K Units)
Figure 28. Americas Viral Inactivation Kits Revenue 2018-2023 ($ Millions)
Figure 29. APAC Viral Inactivation Kits Sales 2018-2023 (K Units)
Figure 30. APAC Viral Inactivation Kits Revenue 2018-2023 ($ Millions)
Figure 31. Europe Viral Inactivation Kits Sales 2018-2023 (K Units)
Figure 32. Europe Viral Inactivation Kits Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Viral Inactivation Kits Sales 2018-2023 (K Units)
Figure 34. Middle East & Africa Viral Inactivation Kits Revenue 2018-2023 ($ Millions)
Figure 35. Americas Viral Inactivation Kits Sales Market Share by Country in 2022
Figure 36. Americas Viral Inactivation Kits Revenue Market Share by Country in 2022
Figure 37. Americas Viral Inactivation Kits Sales Market Share by Type (2018-2023)
Figure 38. Americas Viral Inactivation Kits Sales Market Share by Application (2018-2023)
Figure 39. United States Viral Inactivation Kits Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Viral Inactivation Kits Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Viral Inactivation Kits Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Viral Inactivation Kits Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Viral Inactivation Kits Sales Market Share by Region in 2022
Figure 44. APAC Viral Inactivation Kits Revenue Market Share by Regions in 2022
Figure 45. APAC Viral Inactivation Kits Sales Market Share by Type (2018-2023)
Figure 46. APAC Viral Inactivation Kits Sales Market Share by Application (2018-2023)
Figure 47. China Viral Inactivation Kits Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Viral Inactivation Kits Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Viral Inactivation Kits Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Viral Inactivation Kits Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Viral Inactivation Kits Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Viral Inactivation Kits Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Viral Inactivation Kits Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Viral Inactivation Kits Sales Market Share by Country in 2022
Figure 55. Europe Viral Inactivation Kits Revenue Market Share by Country in 2022
Figure 56. Europe Viral Inactivation Kits Sales Market Share by Type (2018-2023)
Figure 57. Europe Viral Inactivation Kits Sales Market Share by Application (2018-2023)
Figure 58. Germany Viral Inactivation Kits Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Viral Inactivation Kits Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Viral Inactivation Kits Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Viral Inactivation Kits Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Viral Inactivation Kits Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Viral Inactivation Kits Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Viral Inactivation Kits Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Viral Inactivation Kits Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa Viral Inactivation Kits Sales Market Share by Application (2018-2023)
Figure 67. Egypt Viral Inactivation Kits Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Viral Inactivation Kits Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Viral Inactivation Kits Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Viral Inactivation Kits Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Viral Inactivation Kits Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Viral Inactivation Kits in 2022
Figure 73. Manufacturing Process Analysis of Viral Inactivation Kits
Figure 74. Industry Chain Structure of Viral Inactivation Kits
Figure 75. Channels of Distribution
Figure 76. Global Viral Inactivation Kits Sales Market Forecast by Region (2024-2029)
Figure 77. Global Viral Inactivation Kits Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Viral Inactivation Kits Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global Viral Inactivation Kits Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global Viral Inactivation Kits Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Viral Inactivation Kits Revenue Market Share Forecast by Application (2024-2029)


❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ ウイルス不活化キットのグローバル市場予測2023-2029(Global Viral Inactivation Kits Market Growth 2023-2029)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆